- 2
- 1
Francois Chevalier
François Chevalier
3
Documents
Affiliations actuelles
- 1061150
- 53953
- 56527
- 20287
Identifiants chercheurs
- francois-chevalier
- 0000-0002-8488-2324
- IdRef : 060862440
Présentation
Dr. François Chevalier, PhD, HDR, with a background in protein chemistry and molecular biology, received his doctoral degree in biochemistry in 2001 (INRA, Nantes, France), for the biochemical characterization of glycated proteins. He did a 5 years post-doctoral research positions in Montpellier (INRA, France) with a special focus on global analysis of proteins using two-dimensional electrophoresis and mass spectrometry. Following a research positions in Cork (UCC, Ireland) with a study of protein quality using proteomics tools, he is currently employed in CEA (DRF-IRAMIS-CIMAP in Caen) as team leader in radiation biology in the ARIA group (Applications in Radiobiology with Accelerated Ions).
Dr. François Chevalier is specialized in radiation-biology of radioresistant cancer models and bystander effects in a context of hadrontherapy.
He has published more than 70 scientific and technical papers in peer reviewed journals.
Domaines de recherche
Cancer
Biologie cellulaire
Génomique, Transcriptomique et Protéomique [q-bio.GN]
Biochimie, Biologie Moléculaire
Publications
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 3
|
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic SolutionsCancers, 2023, 15 (7), pp.1962. ⟨10.3390/cancers15071962⟩
Article dans une revue
hal-04058836v1
|
Hadrontherapy and PARP inhibitors effects on chondrosarcoma cancer stem cellsICRR 2023, Aug 2023, Montréal Québec, Canada
Poster de conférence
hal-04217091v1
|
|
|
Impact de l'hadronthérapie par ions carbone et protons sur les cellules souches cancéreuses de chondrosarcome en hypoxie14éme journée scientifique de la cancéropôle Nord-Ouest, May 2022, Deauville, France
Poster de conférence
hal-03757233v1
|